This is a multi-licensed, privately held Peruvian cannabis company that specializes in manufacturing, importing, and distributing medical cannabis products. With over 60% market share, a telehealth clinic, and established sales channels, this company is bound for continual dominance in the Peruvian and South American medical cannabis markets.
Key Highlights
Established Operations:
- A trusted government partner, they are consistently selected for public tenders to supply medical cannabis.
- Specializing in manufacturing, bulk and finished packaging, labeling, wholesale, retail sales, storage, and distribution.
- Registered "Registro Sanitario" products are approved by DIGEMID, ensuring placement on pharmacy shelves.
Product Portfolio:
- Offers tinctures, vaporizers, gummies, and topicals under branded retail lines and wholesale.
- They hold over 50 patented formulations making use of Peru's rich natural resources.
Market Penetration:
- Exclusive distribution agreements with Peru’s largest pharmacy chain (2,000+ points of sale) and other partners in Peru and Bolivia.
- Projected to have a 70-75% market share increase by Q2 2024 by expanding product selections.
Expansion Potential:
- Secured one of Panama’s seven cannabis licenses, with product registration planned for Q3/Q4 2024.
- Positioned to expand in major LATAM markets, including Mexico, Argentina, Colombia, Panama, Chile, and Brazil, leveraging regulatory approvals and distribution networks.
Technology Integration:
- Operates a telemedicine portal with an integrated logistics model for managing orders.
Financial Stability:
- They are self-funded and have a debt-free operation with established brands and growing revenue streams.
Investment Opportunity:
- Asking Price: $6 million USD (negotiable).
- Includes: Licenses, intellectual property (registered products, brands, patents, and goodwill), and leased premises.
- Open to outright divestiture or strategic partnership opportunities.
Acquire a leading cannabis company with a large market share, established brands, and a significant potential for growth in the LATAM cannabis sector. Ideal for investors seeking entry into the Peruvian and South American markets with immediate expansion capabilities.
